Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) (Letter of intent due date: June 17)
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities (Expiration date: June 06, 2026
Innovations in Measuring Community Perceptions Challenge (Webinar on June 6) (Submission period ends: July 31)
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
Social work students and apprentices: submit your best argument for this year’s question for the chance to win one of four grants of £500.
Social work students and apprentices: submit your best argument for this year’s question for the chance to win one of four grants of £500 (Closes 23 June)
RfPB Under-represented disciplines and specialisms highlight notice: Methodologists (Expression of interest due by 16 August)
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Cooperative Agreements for 988 Suicide and Crisis Lifeline Crisis Center Follow-Up Programs (Due by June 26)
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 – Clinical Trial Optional)
Children and Youth Resilience Challenge: Innovative, community-led solutions to advance the mental health of children and youth (Phase 1 open until 07/07)
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) (Letter of Intent Due 30 days prior to the application due date)
Biden-Harris Administration Announces Nearly $100 Million in Continued Support for Mental Health and Student Wellness Through Bipartisan Safer Communities Act
Notice of Special Interest (NOSI): The HIV-HCV-Substance Use Disorder Syndemic: Therapeutic Approaches (Expiration Date: Sept 8)
HHS Announces Over $65 Million to Address the Maternal Health Crisis and Invest in New Approaches to Care
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) (Letter of Intent Due 30 days prior to the application due date)
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed) (Letter of intent due date: Sept 23)
Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) (Open Date (Earliest submission date: May 19
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (Letter of Intent Due 30 days prior to the Application Due date)
Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (
Virginia Commonwealth University School of Social Work: Postdoctoral Fellowship in Research on Social Determinants of Health & Prevention Sciences
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional) (Letter of Intent due 30 days prior to the application due date)
AIM-AHEAD Consortium Development Projects to Advance Health Equity: Call for Proposals (Letter of intent due date: May 20
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 – Clinical Trial Required) (Letter of intent due 30 days prior to application due date)
Prevention Services Evaluation Partnerships: Building Evidence for Mental Health, Substance Use, In-home Parent Skill-based, and Kinship Navigator Programs and Services (Estimated Application Due Date: June 11)
SAMHSA Funding Opportunity: Substance Use and HIV Prevention Navigator Program for Racial/Ethnic Minorities (Due by June 20)
Center for Research on Hispanic Children and Families (Current Closing Date for Applications: June 07)